Screening for depression and anxiety in women with breast and gynaecologic cancer: Course and prevalence of morbidity over 12 months

Psycho-Oncology

Volumn 22, Issue 9, 2013, Pages 2071-2078

  Stafford, Lesley ^a,b   Judd, Fiona ^a,c   Gibson, Penny ^a   Komiti, Angela ^a   Mann, G Bruce ^c,d   Quinn, Michael ^a,c  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Royal Womens Hospital Melbourne   (Australia)

Author keywords

anxiety; cancer; depression; distress; oncology; screening

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; BREAST CANCER; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; FEMALE; GYNECOLOGIC CANCER; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MANAGEMENT; MENTAL HEALTH; MORBIDITY; PATIENT REFERRAL; PREVALENCE; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT;

ANXIETY; CANCER; DEPRESSION; DISTRESS; ONCOLOGY; SCREENING;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; BREAST NEOPLASMS; DEPRESSION; DISEASE PROGRESSION; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; TIME FACTORS;

EID: 84883142954     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3253     Document Type: Article

References (66)

1. National Comprehensive Cancer Network. Distress management: clinical practice guidelines. J Natl Compr Canc Netw 2003; 1: 344-374.
2. National Institute for Clinical Excellence. NICE: Guidelines on Cancer Services: Improving Supportive and Palliative Care for Adults with Cancer. London: National Institute for Clinical Excellence; 2004.
3. National Breast Cancer Centre and National Cancer Control Initiative. Clinical Practice Guidelines for the Psychosocial Care of Adults with Cancer. Camperdown, Australia: National Breast Cancer Centre; 2003.
4. Patrick DL, Ferketich SL, Frame PS,. National Institutes of Health State-of-the-Science Conference Statement. Symptom management in cancer: pain, depression, and fatigue. J Natl Cancer Inst 2004; 32: 9-16.
5. Adler NE, Page AEK,. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington, DC: The National Academies Press; 2007.
6. Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, MacRae JH, Martin M, Pelletier G, Robinson J, Simpson JS, Speca M, Tillotson L, Bultz BD,. High levels of untreated distress and fatigue in cancer patients. Br J Cancer 2004; 90: 2297-2304.
7. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S,. The prevalence of psychological distress by cancer site. Psycho-Oncology 2001; 10: 19-28.
8. Derogatis LR, Morrow GR, Fetting J,. The prevalence of psychiatric disorders among cancer patients. JAMA 1983; 249: 751-757.
9. Fallowfield L, Ratcliffe D, Jenkins V, Saul J,. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001; 84: 1011-1015.
10. Osborn RL, Demoncada AC, Feuerstein M,. Psychosocial interventions for depression, anxiety and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med 2006; 36: 13-34.
11. Jacobson PB, Jim HS,. Psychosocial interventions for anxiety and depression in adult cancer patients: achievements and challenges. CA Cancer J Clin 2008; 58: 214-230.
12. Andrykowski MA, Manne SL,. Are psychological interventions effective and accepted by cancer patients? I. Standards and levels of evidence. Ann Beh Med 2006; 32: 93-97.
13. Satin JR, Linden W, Phillips MJ,. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 2009; 115: 5349-61.
14. Kondryn HJ, Edmondson CL, Hill J, Eden TO,. Treatment non-adherence in teenage and young adult patients with cancer. Lancet Oncol 2011; 12: 100-108.
15. Greer JA, Pirl WF, Park ER, Lynch TJ, Temel JS,. Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer. J Psychosom Res 2008; 65: 549-552.
16. Froijd C, Lampic C, Larsson G, von Essen L,. Is satisfaction with doctors' care related to health-related quality of life, anxiety and depression among patients with carcinoid tumours? A longitudinal report. Scand J Caring Sci 2009; 23: 107-116.
17. Frick E, Tyroller M, Panzer M,. Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: a cross-sectional study in a community hospital outpatient centre. Eur J Cancer Care (Engl) 2007; 16: 130-136.
18. Carlson LE, Bultz B,. Benefits of psychosocial oncology care: improved quality of life and medical cost offset. Health Qual Life Outcomes 2003; 1: 8.
19. Simpson JSA, Carlson LE, Trew M,. Impact of a group psychosocial intervention on health care utilization by breast cancer patients Cancer Practice 2001; 9: 19-26.
20. Keller M, Sommerfeldt S, Fischer C, Knight L, Riesbeck M, Lowe B, Herfarth C, Lehnert T,. Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach. Ann Oncol 2004; 15: 1243-1249.
21. Söllner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G, Maislinger S,. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 2001; 84: 179-185.
22. Holland JC,. History of psycho-oncology: overcoming attitudinal and conceptual barriers. Psychosom Med 2002; 64: 206-21.
23. Detmar SB, Aaronson NK, Wever LD, Muller MJ, Schornagel JH,. How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues. J Clin Oncol 2000; 18: 3295-301.
24. Vodermaier A, Linden W, Siu C,. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 2009; 101: 1464-1488.
25. Palmer SC, Taggi A, DeMichele A, Coyne JC,. Is screening effective in detecting untreated psychiatric disorders among newly diagnosed breast cancer patients? Cancer 2012; 118: 2735-43.
26. Bidstrup PE, Johansen C, Mitchell AJ,. Screening for cancer-related distress: summary of evidence from tools to programmes. Acta Oncol 2011; 50: 194-204.
27. Meijer A, Roseman M, Milette K, Coyne JC, Stefanek ME, Ziegelstein RC, Arthurs E, Leavens A, Palmer SC, Stewart DE, de Jonge P, Thombs BD,. Depression screening and patient outcomes in cancer: a systematic review. PLoS One 2011; 6: e27181.
28. Jacobsen PB,. Screening for psychological distress in cancer patients: challenges and opportunities. J Clin Oncol 2007; 25: 4526-7.
29. Mitchell AJ,. Pooled results from 38 analyses of the accuracy of the Distress Thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol 2007; 25: 4670-81.
30. Carlson L, Bultz B,. Cancer distress screening: needs, models and methods. J Psychosom Res 2003; 55: 403-9.
31. Radloff LS,. The CESD scale: a self report scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
32. Vodermaier A, Linden W, Siu C,. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 2009; 101: 1464-88.
33. Mitchell AJ, Meader N, Davies E, Clover K, Carter GL, Loscalzo MJ, Linden W, Grassi L, Johansen C, Carlson LE, Zabora J,. Meta-analysis of screening and case finding tools for depression in cancer: evidence based recommendations for clinical practice on behalf of the Depression in Cancer Care consensus group. J Affect Disord 2012; 140: 149-60.
34. Luckett T, Butow PN, King MT, Oguchi M, Heading G, Hackl NA, Rankin N, Price MA,. A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Support Care Cancer 2010; 18: 1241-62.
35. Bodurka-Bevers D, Basen-Enqquist K, Carmakc CL, Fitzgerald MA, Wolf JK, De Moor C, Gershenson DM,. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol 2000; 78: 302-308.
36. Mulrow CD, William JW, Gerety MB, Ramirez G, Montiel OM, Kerber C,. Case-finding instruments for depression in primary care settings. Ann Intern Med 1995; 122: 913-21.
37. Andresen EM, Malmgren JA, Carter WB, Patrick D,. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 1994; 10: 77-84.
38. Zigmond AS, Snaith RP,. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-70.
39. Carey M, Noble N, Sanson-Fisher R, MacKenzie L,. Identifying psychological morbidity among people with cancer using the Hospital Anxiety and Depression Scale: time to revisit first principles? Psycho-Oncology 2012; 21: 229-38.
40. Vodermaier A, Millman RD,. Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer 2011; 19: 1899-908.
41. Bjelland I, Dahl AA, Haug TT, Neckelmann D,. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
42. Goldberg L,. A broad-bandwidth, public-domain personality inventory measuring the lower-level facets of several five-factor models. In Personality Psychology in Europe., Mervielde I, Deary I, De Fruyt F, Ostendorf F,. Tilburg: Tilburg University Press; 1999.
43. Goldberg L,. International Personality Item Pool. 2001.ipip.ori.org/
44. Buchanan T, Johnson J, Goldberg L,. Implementing a five-factor personality inventory for use on the internet. Eur J Psychol Assess 2005; 21: 115-27.
45. Costa PTJ, McCrae RR,. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI): Professional Manual. Odessa, Florida: Psychological Assessment Resources; 1992.
46. Eysenck S, Eysenck H, Barrett P,. A revised version of the Psychoticism scale. Pers Individ Dif 1985; 6: 21-9.
47. Gow A, Whiteman M, Pattie A, Deary I,. Goldberg's 'IPIP' Big-Five factor markers: internal consistency and concurrent validation in Scotland. Pers Individ Dif 2005; 39: 317-29.
48. Watson D, Clark LA,. Negative affectivity: the disposition to experience aversive emotional states. Psychol Bull 1984; 96: 465-490.
49. Watson D, Pennebaker JW,. Health complaints, stress and distress: exploring the central role of negative affectivity. Psychol Rev 1989; 96: 234-254.
50. Hirschfeld RM, Klerman GL, Lavori P, Keller MB, Griffith P, Coryell W,. Premorbid personality assessments of first onset of major depression. Arch Gen Psychiatry 1989; 46: 345-50.
51. Krueger RF, Caspi A, Moffitt TE, Silva PA, McGee R,. Personality traits are differentially linked to mental disorders: a multi-trait multi-diagnosis study of an adolescent birth cohort. J Abnorm Psychol 1996; 105: 299-312.
52. Hirschfeld RM, Klerman GL, Andreasen NC, Clayton PJ, Keller MB,. Psychosocial predictors of chronicity in depressed patients. Br J Psychiatry 1986; 148: 648-54.
53. Scott J, Eccleston D, Boys R,. Can we predict the persistence of depression ? Br J Psychiatry 2002; 161: 633-7.
54. Okamura M, Yamawaki S, Akechi T, Taniguck K, Uchitomi Y,. Psychiatric disorders following first breast cancer recurrence: prevalence, associated factors and relationship to quality of life. Jpn J Clin Oncol 2005; 35: 302-9.
55. Ranchor AV, Sanderman R, Steptoe A, Wardie J, Miedema I, Ormel J,. Pre-morbid predictors of psychological adjustment to cancer. Qual Life Res 2002; 11: 101-113.
56. Carter G, Britton B, Clover K, Rogers K, Adams C, McElduff P,. Effectiveness of QUICATOUCH: a computerised touch screen evaluation for pain and distress in ambulatory oncology patients in Newscastle Australia., Psycho-Oncol 2012; 21: 1149-1157.
57. Den Oudsten BL, Van Heck GL, Van der Steeg AFW, Roukema JA, De Vries J,. Predictors of depressive symptoms 12 months after surgical treatment of early-stage breast cancer. Psycho-Oncology 2009; 18: 1230-7.
58. Ferrandina G, Mantegna G, Petrillo M, Fuoco G, Venditti L, Terzano S, Moruzzi C, Lorusso D, Marcellusi A, Scambia G,. Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study. Gynecol Oncol 2012; 124: 389-394.
59. Hoey LM, Ieropoli SC, White VM, Jefford M,. Systematic review of peer-support programs for people with cancer. Patient Educ Couns 2008; 70: 315-37.
60. Palmer SC,. Clinical trial did not demonstrate benefits of screening patients with cancer for distress. J Clin Oncol 2011; 29: e277-8.
61. Pyne JM, Rost KM, Farahati F,. One size fits some: the impact of patient treatment attitudes on the cost effectiveness of a depression primary-care intervention. Psychol Med 2005; 35: 839-54.
62. Nutting PA, Rost KM, Dickinson M,. Barrier to initiating depression treatment in primary care practice. J Gen Intern Med 2002; 17: 103-111.
63. Baas KDW, KA, van Weert H,. Screening for depression in high-risk groups: prescriptive cohort study in general practice. Br J Psychiatry 2009; 194: 399-403.
64. Baker-Glenn E, Park B, Granger L, Symonds P, Mitchell AJ,. Desire for psychological support in cancer patients with depression or distress: validation of a simple help question. Psycho-Oncology 2011; 20: 525-531.
65. Carlson LE, Groff LS, Maciejewski O, Bultz B,. Screening for distress in lung and breast cancer outpatients: a randomized controlled trial. J Clin Oncol 2010; 28: 4884-91.
66. Merckaert I, Libert Y, Messin S, Milani M, Slachmuylder JL, Razavi D,. Cancer patients' desire for psychological support: prevalence and implications for screening patients' psychological needs. Psycho-Oncology 2010; 19: 141-149.